A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer

This study has been completed.

Study NCT00069095 Information provided by Hoffmann-La Roche

First Received: September 15, 2003 Last Updated: November 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2009
Estimated Primary Completion Date:	No date given